Bile Acid Sequestrants for Lipid and Glucose Control
نویسندگان
چکیده
منابع مشابه
Bile Acid Sequestrants for Lipid and Glucose Control
Bile acids are generated in the liver and are traditionally recognized for their regulatory role in multiple metabolic processes including bile acid homeostasis, nutrient absorption, and cholesterol homeostasis. Recently, bile acids emerged as signaling molecules that, as ligands for the bile acid receptors farnesoid X receptor (FXR) and TGR5, activate and integrate multiple complex signaling p...
متن کاملLipid Control: Niacin, Bile Acid Sequestrants, Fibrates
From the name itself, lipoproteins are made up of complexes of lipids and proteins that primarily work as the transport system for cholesterol, triglycerides and other significant lipids needed by the body. Previously, the study of conditions related to problems in the metabolism of lipoproteins has been exclusive only for researchers focusing on lipids. However, it has been integrated into the...
متن کاملBile acid sequestrants: more than simple resins.
PURPOSE OF REVIEW Bile acid sequestrants (BAS) have been used for more than 50 years in the treatment of hypercholesterolemia. The last decade, bile acids are emerging as integrated regulators of metabolism via induction of various signal transduction pathways. Consequently, BAS treatment may exert unexpected side-effects. We discuss a selection of recently published studies that evaluated BAS ...
متن کاملBile Acid-Induced Virulence Gene Expression of Vibrio parahaemolyticus Reveals a Novel Therapeutic Potential for Bile Acid Sequestrants
Vibrio parahaemolyticus, a bacterial pathogen, causes human gastroenteritis. A type III secretion system (T3SS2) encoded in pathogenicity island (Vp-PAI) is the main contributor to enterotoxicity and expression of Vp-PAI encoded genes is regulated by two transcriptional regulators, VtrA and VtrB. However, a host-derived inducer for the Vp-PAI genes has not been identified. Here, we demonstrate ...
متن کاملEffect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials
INTRODUCTION In addition to the lipid-lowering effect of bile acid sequestrants (BASs), they also lower blood glucose and, therefore, could be beneficial in the treatment of patients with type 2 diabetes mellitus (T2DM). Three oral BASs are approved by the US Food and Drug Administration (FDA) for the treatment of hypercholesterolaemia: colestipol, cholestyramine and colesevelam. The BAS colest...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Diabetes Reports
سال: 2010
ISSN: 1534-4827,1539-0829
DOI: 10.1007/s11892-009-0087-5